Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.24.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Expense

Stock-based compensation expense is as follows:

 

    2023     2022  
    For the Year Ended  
    December 31,  
    2023     2022  
Research and development   $ 84     $ 18  
Sales and marketing     377       68  
General and administrative     934       1,426  
Cost of revenues     101       39  
Total   $ 1,496     $ 1,551  
Schedule of Stock Option Activity

Stock option activity for the years ended December 31, 2023 and 2022 is as follows:

 

          Weighted average exercise price     Weighted average remaining contractual life     Aggregate Intrinsic  
    Options     per share     (in years)     Value*  
Outstanding at January 1, 2022     95,413     $ 40.00       6.73     $ 0  
Options granted     4,414,419     $ 0.44                  
Options exercised         $                  
Options forfeited     (15,303 )   $ 33.65                  
Options cancelled     (18,314 )   $ 49.67                  
Outstanding at December 31, 2022     4,476,215     $ 0.95       9.76     $ 358  
                                 
Options granted     1,803,000     $ 0.57                  
Options exercised     (1,125,000 )   $ 0.42                  
Options forfeited         $                  
Options cancelled     (7,833 )   $ 4.50                  
Outstanding at December 31, 2023     5,146,382     $ 0.93       8.94     $ 1,370  
                                 
Vested and expected to vest at December 31, 2023     5,146,382     $ 0.93       8.94     $ 1,370  
Exercisable at December 31, 2023     609,948     $ 4.00       8.55     $ 167  

 

* The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the balance sheet date.
Schedule of Fair Value Option grants

The following represents the weighted-average assumptions used in the Black-Scholes valuation model by the Company in calculating the fair value of each stock option granted during the year ended December 31, 2023:

 

Expected dividend yield     0 %
Risk-free interest rate     3.81 %
Expected volatility     114 %
Expected life (in years)     5.6  
Schedule of Outstanding Restricted Stock Units

The following table summarized the outstanding RSUs as of December 31, 2023:

 

    RSUs  
Outstanding at January 1, 2022     860,888  
Granted     445,200  
Released     (619,042 )
Forfeited     (5,200 )
Outstanding at December 31, 2023     681,846